For employers, health plans, and benefits consultants
Better metabolic health support. More control over GLP-1 cost.
Levels gives your members metabolic health support and your organization more visibility across GLP-1 eligibility, participation, and spend.
62,236
consented users in our longitudinal IRB study
1.15B
glucose readings across 3.5 years
HIPAA + SOC 2 Type 2
Security and privacy controls independently assessed
GLP-1 demand is growing faster than care and benefit models can govern.
Spend keeps climbing, but about half of members stop within the first year, and most of the lost weight comes back. Organizations are paying for results that do not hold.
Unpredictable cost exposure
Demand and renewals can outpace annual budgets and plan assumptions.
Members stop early
About half discontinue GLP-1 therapy within the first year, well before results have a chance to hold.
Nothing beyond the prescription
Medication alone does not build the daily habits that keep results in place once treatment ends.
Sources: Discontinuation and employer cost pressure, Peterson Health Technology Institute, Employer Approaches to GLP-1 Coverage market trend report, December 2025. Weight regain after treatment withdrawal, Wilding et al., STEP 1 trial extension, Diabetes, Obesity and Metabolism, 2022.
How the program works
From prevention through treatment, Levels connects the full cost and care journey.
Levels supports metabolic health for all your members. When GLP-1s are a part of their health journey, our GLP-1 companion program adds education and ongoing support.
Levels Wellness Benefit
Support metabolic health before medication is needed.
Members use CGM, labs, food-logging, and personalized guidance to understand and address the behaviors driving metabolic risk.
GLP-1 Companion Program
Support treatment and ongoing care beyond it.
Included with every level of GLP-1 management: education, nutrition, and movement support, plus side-effect guidance personalized to each user.
One coherent experience before, during, and after medication
In the Levels app
The member experience
What members have experienced with Levels.
Levels turns CGM, labs, food, activity, sleep, and care-team guidance into personalized next steps. Members learn what works for their body, build habits that can last beyond treatment, and get support at every step in their health journey. The stories featured here show how individual members used those insights within their broader health journeys.
“Levels provides x-ray vision to how my body is responding to food and actions.”
Member stories
See all member stories
How Mike reversed Type 2 diabetes and lost more than 50 pounds
Read the story
How Debbie overcame food addiction and reversed her diabetes
Read the story
How Raeann reversed Type 2 diabetes and dropped her A1C from 12.1 to 6.0
Read the storyThese are individual member experiences, not estimates of expected results. Outcomes reflect each member’s broader lifestyle and medical circumstances; see the full stories for context.
The Levels evidence
Research at real-world scale.
Our IRB-approved longitudinal study follows 62,236 consented members and more than one billion CGM readings across 3.5 years. In analyses of members with elevated baseline biomarkers, researchers observed improvements across several markers. That included participants whose BMI moved below the range where GLP-1s are typically prescribed.
Our study, in numbers. Here's exactly what we found.
Study snapshot
62,236
consented users
- 3.5 years
- of data
- 1.15B
- glucose readings
Percent whose BMI fell below GLP-1 prescribing thresholds at one year
GLP-1s for weight management are labeled for a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related condition.
BMI 30
or higher. n=1,102
BMI 27
with a risk factor. n=948
Levels longitudinal IRB-approved study, measured at one year. Observational, participant-funded.
Who it's for
One platform, tailored to the decisions each stakeholder owns.
Employers
The challenge
GLP-1 spend is climbing, and you need results that outlast the prescription.
How we help
Levels packages the interventions with the strongest evidence behind them, continuous glucose feedback, food logging, and structured behavior support, so your members build habits that hold after treatment ends.
Health plans
The challenge
You need to govern utilization across a population without adding friction for members.
How we help
Levels supports members before, during, and after treatment, with participation reporting you can actually act on at renewal.
Benefits consultants
The challenge
You need to recommend a plan design you can defend to a sophisticated client.
How we help
Levels gives you research, stated methods, and clear limitations, so nothing in your recommendation gets walked back later.
Decision-ready resources
Everything your team needs to evaluate Levels.
Research evidence, economic mechanics, and operational detail for the people who will scrutinize each.
Talk with LevelsResearch evidence
Longitudinal IRB-approved study: methods and findings
Study design, sample, and observed findings, with the limitations that apply to them.
Whitepaper
Beyond the Prescription
Why personalization determines the return on your GLP-1 investment.
Member stories
How members actually use Levels
Published stories on glucose feedback, food logging, and habit change.
Implementation
Integration and launch
Eligibility files, member communications, reporting, security, and governance. Available in a consultation.
Your members, your strategy
Take control of unpredictable GLP-1 spend.
Tell us about your population and current approach. We'll follow up with a plan built around your needs.